Primary Care Intervention Strategy for Anxiety Disorders

NCT00347269 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1004

Last updated 2017-05-19

Study results available
· View outcomes & findings →

Summary

This study will compare the effectiveness of an intervention strategy for the treatment of people with post traumatic stress disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder in the primary care setting.

Conditions

Interventions

BEHAVIORAL

Cognitive-behavioral therapy

Participants in CALM will choose to receive CBT, medication, or both for the treatment of their anxiety. CBT includes computer-assisted CBT with an anxiety clinical specialist.

DRUG

Psychotropic medication optimization

For those participants in CALM who choose medication, the ACS will facilitate the delivery of, and adherence to, anti-anxiety medication which will be prescribed by the participants' PCP.

BEHAVIORAL

Treatment as Usual

Participants in the control group will receive standard treatment from their PCP.

Sponsors & Collaborators

Principal Investigators

  • Peter P. Roy-Byrne, MD · University of Washington

  • Cathy D. Sherbourne, PhD · RAND Corporation, Santa Monica, CA

  • Michelle G. Craske, PhD · University of California, Los Angeles

  • Greer Sullivan, MD, MSPH · University of Arkansas for Medical Sciences, Little Rock, AR

  • Murray B. Stein, MD, MPH · University of California, San Diego, San Diego, CA

  • Kristin Bumgardner, BS · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347269 on ClinicalTrials.gov